World's Best Scientists 2026 revealed!
Acta Pharmaceutica Sinica B
H-index 67

Acta Pharmaceutica Sinica B

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 167 136 222 41
Medicine 629 58 86 31

Additional Metrics

Number of Best Scientists*: 497
Documents by Best Scientists*: 640
Top 100 Ranked Scientists*: 12
SCIMAGO H-index: 123
SCIMAGO SJR: 3.489
Impact Factor: 14.6

Overview

Top Research Topics at Acta Pharmaceutica Sinica B?

The scientific interests tackled in the journal are Cancer research, Pharmacology, Drug delivery, In vivo and Biochemistry. Cancer cell, Cancer, Metastasis and Immune system are some topics wherein Cancer research research discussed in the journal have an impact. The journal aims to address concerns in Immune system, specifically in the areas of Immunotherapy and Cancer immunotherapy.

Pharmacokinetics, Drug and Bioavailability are all aspects of Pharmacology research featured in the journal. The study of Nanotechnology serves as the foundation of the Drug delivery research discussed in the journal. The journal connects research in In vivo with the related topic of In vitro.

  • Cancer research (18.95%)
  • Pharmacology (18.20%)
  • Drug delivery (9.77%)

What are the most cited papers published in the journal?

  • Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. (984 citations)
  • HIF-1α pathway: role, regulation and intervention for cancer therapy (743 citations)
  • Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges (577 citations)

Research areas of the most cited articles at Acta Pharmaceutica Sinica B:

The journal publications tackle a plethora of topics, such as Pharmacology, Drug delivery, Drug, Cancer research and Nanotechnology. The most cited publications address concerns in the field of Pharmacology by exploring it in line with topics in In vivo which intersect with In vitro subjects. The most cited papers explore topics in Cancer research which can be helpful for research in disciplines like Cancer cell, Cancer, Internal medicine and Metastasis.

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Acta Pharmaceutica Sinica B (based on the number of publications) are:

  • Jian-Dong Jiang (22 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Jiangong Shi (15 papers) absent at the last edition,
  • Wei Wu (14 papers) published 7 papers at the last edition, 6 more than at the previous edition,
  • Chuanbin Wu (14 papers) published 2 papers at the last edition, 3 less than at the previous edition,
  • Guanhua Du (14 papers) published 3 papers at the last edition, 2 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Acta Pharmaceutica Sinica B (based on the number of publications) are:

  • Peking Union Medical College (209 papers) published 39 papers at the last edition, 18 more than at the previous edition,
  • Chinese Academy of Sciences (95 papers) published 35 papers at the last edition, 20 more than at the previous edition,
  • Fudan University (73 papers) published 25 papers at the last edition, 12 more than at the previous edition,
  • Sun Yat-sen University (70 papers) published 28 papers at the last edition, 12 more than at the previous edition,
  • China Pharmaceutical University (68 papers) published 36 papers at the last edition, 24 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.95% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 59.09% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.23% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.64% of all publications and 17.05% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.

    Sonal V Bhujbal;Biplob Mitra;Uday Jain;Yuchuan Gong

    (2021)
    473 Citations
  • Metal-organic frameworks for advanced drug delivery

    Siyu He;Li Wu;Xue Li;Hongyu Sun

    (2021)
    461 Citations
  • Ginsenosides in Panax genus and their biosynthesis

    Maoqi Hou;Rufeng Wang;Shujuan Zhao;Zhengtao Wang

    (2021)
    288 Citations
  • Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways

    Xiang Wang;Xiang Wang;Xinxin Chen;Wenqian Zhou;Wenqian Zhou;Hongbo Men;Hongbo Men

    (2021)
    273 Citations
  • Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development

    Yixin Sun;Dongyang Zhao;Gang Wang;Yang Wang

    (2020)
    257 Citations
  • Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.

    Minlin Jiang;Keyi Jia;Lei Wang;Wei Li

    (2021)
    172 Citations
  • Bioactive natural compounds against human coronaviruses: a review and perspective

    Yanfang Xian;Juan Zhang;Zhaoxiang Bian;Hua Zhou

    (2020)
    171 Citations
  • Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release

    (2021)
    170 Citations
  • Combating COVID-19 with integrated traditional Chinese and Western medicine in China

    Liqiang Ni;Lili Chen;Xia Huang;Chouping Han

    (2020)
    162 Citations
  • Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

    Tingting Yan;Nana Yan;Ping Wang;Ping Wang;Yangliu Xia;Yangliu Xia

    (2020)
    155 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but not ready to commit to a full medical degree, there are excellent alternatives to consider. An online ASN program offers a foundational path into nursing with flexible learning options and quicker entry into the workforce.

Nutrition also plays a critical role in healthcare, and pursuing one of the best online nutrition programs can open doors to careers in dietetics, wellness coaching, and public health.

For those aiming to advance into healthcare management, a degree from a CAHME accredited online MHA program provides the necessary skills to oversee medical facilities and improve healthcare delivery.

Finally, nurses looking to elevate their clinical expertise without the requirement of onsite training can explore online DNP programs without clinicals. These programs offer advanced practice education in a flexible format, catering to working professionals.

Best Scientists Contributing to This Journal